Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
88.73
+2.14 (2.47%)
At close: Jul 19, 2024, 4:00 PM
10.18
-78.55 (-88.52%)
After-hours: Jul 20, 2024, 1:23 PM EDT
Haemonetics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Haemonetics stock have an average target of 109.5, with a low estimate of 94 and a high estimate of 125. The average target predicts an increase of 23.41% from the current stock price of 88.73.
Analyst Consensus: Buy
* Price targets were last updated on Jun 12, 2024.
Analyst Ratings
The average analyst rating for Haemonetics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 3 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold → Strong Buy Upgrades $112 | Hold → Strong Buy | Upgrades | $112 | +26.23% | Jun 12, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $115 → $125 | Buy | Maintains | $115 → $125 | +40.88% | May 10, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $105 → $107 | Buy | Maintains | $105 → $107 | +20.59% | May 10, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 10, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $105 | Buy | Maintains | $105 | +18.34% | Apr 12, 2024 |
Financial Forecast
Revenue This Year
1.41B
from 1.31B
Increased by 8.02%
Revenue Next Year
1.49B
from 1.41B
Increased by 5.37%
EPS This Year
4.64
from 2.29
Increased by 102.70%
EPS Next Year
5.49
from 4.64
Increased by 18.22%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.5B | 1.6B | 1.8B | 2.0B |
| Avg | 1.4B | 1.5B | 1.6B | 2.0B |
| Low | 1.4B | 1.4B | 1.5B | 1.9B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 13.2% | 14.4% | 22.8% | 26.2% |
| Avg | 8.0% | 5.4% | 8.7% | 21.4% |
| Low | 4.1% | -1.1% | 0.5% | 17.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 4.85 | 6.26 | 7.83 | 8.99 |
| Avg | 4.64 | 5.49 | 6.35 | 8.65 |
| Low | 4.46 | 4.97 | 5.68 | 8.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 111.8% | 34.8% | 42.7% | 41.5% |
| Avg | 102.7% | 18.2% | 15.8% | 36.1% |
| Low | 94.8% | 7.1% | 3.4% | 32.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.